| 17.46 Delayed Data As of 3:59pm ET |  0.00 / 0.00%Today’s Change | 14.91 Today|||52-Week Range 26.25 | -- Year-to-Date |
| Previous close | 17.46 |
| Today’s open | 17.64 |
| Day’s range | 17.28 - 17.76 |
| Volume | 13,818 |
| Average volume (3 months) | 62,014 |
| Market cap | $668.7M |
| Earnings growth (last year) | -41.89% |
| Earnings growth (this year) | +6.14% |
| Earnings growth (next 5 years) | -21.80% |
| Revenue growth (last year) | -38.84% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 22.41 |
| Today’s change | Today’s % change | |
|---|---|---|
| CPRXCatalyst Pharmaceuti... | -0.02 | -0.30% |
| VCELVericel Corp | +0.13 | +0.81% |
| QTRXQuanterix Corp | -2.22 | -8.55% |
| MGNXMacroGenics Inc | -0.23 | -1.75% |
| Next reporting date | September 30, 2019 |
| EPS forecast (this quarter) | -$0.83 |
| Annual revenue (last year) | $81.4K |
| Annual profit (last year) | -$93.8M |
| Net profit margin | -115,247.83% |
Sector Health Technology |
Industry Biotechnology |
CEO & EVP-Marketing & Development Pascal Prigent |
Chief Operating Officer Dean W. Hum |
Corporate headquarters Loos, Nord-pas-de-calais |
